Additional excipient justification [Dissolution / BCS / IVIVC]

posted by nobody – 2014-11-30 21:44 (3872 d 08:03 ago) – Posting: # 13958
Views: 6,903

afaik only WHO considers (some limited) class II APIs egligilbe for biowaivers. Look up literature for ibuprofen to have details on limitations for this approach, has been discussed here in the past iirc...

Regards

nobody

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,687 registered users;
92 visitors (0 registered, 92 guests [including 18 identified bots]).
Forum time: 06:48 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5